Darwin Global Management Ltd. 13D and 13G filings for TG Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 7:45 pm Sale | 2024-09-30 | 13G | TG Therapeutics, Inc. TGTX | Darwin Global Management Ltd. | 0 0.000% | -4,046,598 (Position Closed) | Filing |
| 2024-02-14 3:30 pm Sale | 2023-12-31 | 13G | TG Therapeutics, Inc. TGTX | Darwin Global Management Ltd. | 4,046,598 2.700% | -6,404,643 (-61.28%) | Filing |
| 2023-04-03 08:00 am Purchase | 2023-03-22 | 13G | TG Therapeutics, Inc. TGTX | Darwin Global Management Ltd. | 10,451,241 7.100% | 10,451,241 (New Position) | Filing |